Adult and Pediatric Emergency Department Sexually Transmitted Disease and HIV Screening: Programmatic Overview and Outcomes

Academic Emergency Medicine

Volumn 14, Issue 3, 2007, Pages 250-258

  Mehta, Supriya D ^a   Hall, Jonathan ^a   Lyss, Sheryl B ^a   Skolnik, Paul R ^a   Pealer, Lisa N ^a   Kharasch, Sigmund ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

chlamydia; emergency department; gonorrhea; HIV testing; pediatric; sexually transmitted disease testing

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; ENZYME IMMUNOASSAY; FEMALE; GENE AMPLIFICATION; GONORRHEA; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; BOSTON; CHLAMYDIA INFECTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; GONORRHEA; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROGRAM EVALUATION; RISK FACTORS; RISK-TAKING;

EID: 33847206780     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2006.10.106     Document Type: Article

References (32)

1. Cates W., and American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 26 Suppl (1999) S2-S7
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004 (Vol. 16) (2005), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
3. Centers for Disease Control and Prevention, Division of STD Prevention. Sexually transmitted disease surveillance, 2002 (Sept 2003), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
4. Institute of Medicine. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Committee on Prevention and Control of Sexually Transmitted Diseases (1997), National Academy Press, Washington, DC
5. Hillis S.D., Joesoef R., Marchbanks P.A., Wasserheit J.N., Cates Jr. W., and Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 168 (1993) 1503-1509
6. Scholes D., Stergachis A., Heidrich F.E., Andrilla H., Holmes K.K., and Stamm W.E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 334 (1996) 1362-1366
7. Freedberg K.A., Losina E., Weinstein M.C., et al. The cost-effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med 344 (2001) 824-831
8. Freedberg K.A., Scharfstein J.A., Seage III G.R., et al. The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA 279 (1998) 130-136
9. Monroe K.W., Weiss H.L., Jones M., and Hook III E.W. Acceptability of urine screening for Neisseria gonorrhea and Chlamydia trachomatis in adolescents at an urban emergency department. Sex Transm Dis 30 (2003) 850-853
10. Bachmann L.H., Pigott D., Desmond R., et al. Prevalence and factors associated with gonorrhea and chlamydial infection in at-risk females presenting to an urban emergency department. Sex Transm Dis 30 (2003) 335-339
11. Todd C.S., Haase C., and Stoner B.P. Emergency department screening for asymptomatic sexually transmitted infections. Am J Public Health 91 (2001) 461-464
12. Mehta S.D., Rothman R.E., Kelen G.D., Quinn T.C., and Zenilman J.M. Unsuspected gonorrhea and chlamydia in patients of an urban adult emergency department: a critical population for STD control intervention. Sex Transm Dis 28 (2001) 33-39
13. Mehta S.D., Rompalo A., Rothman R.E., Londner M.S., and Zenilman J.M. Generalizability of STD screening in urban emergency departments: comparison of results from inner city and urban sites in Baltimore, Maryland. Sex Transm Dis 30 (2003) 143-148
14. Mehta S.D., Bishai D., Howell M.R., Rothman R.E., Quinn T.C., and Zenilman J.M. Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients. Sex Transm Dis 29 (2002) 83-91
15. Walensky R.P., Losina E., Malatesta L., et al. Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health 95 (2005) 71-73
16. Centers for Disease Control and Prevention. Routinely recommended HIV testing at an urban urgent care clinic, Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep 50 (2001) 538-541
17. Kelen G.D., Shahan J.B., and Quinn T.C. Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med 33 (1999) 147-155
18. Kendrick S.R., Kroc K.A., Couture E., and Weinstein R.A. Comparison of point-of-care rapid HIV testing in three clinical venues. AIDS 18 (2004) 2208-2210
19. Glick N.R., Silva A., Zun L., and Whitman S. HIV testing in a resource-poor urban emergency department. AIDS Educ Prev 16 (2004) 126-136
20. Pincus J.M., Crosby S.S., Losina E., King E.R., LaBelle C., and Freedberg K.A. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin Infect Dis 37 (2003) 1699-1704
21. Mehta S.D., Rothman R.E., Kelen G.D., Quinn T.C., and Zenilman J.M. Clinical aspects of diagnosis of gonorrhea and chlamydia infection in an acute care setting. Clin Infect Dis 32 (2001) 655-659
22. Crotchfelt K.A., Pare B., Gaydos C., and Quinn T.C. Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol 36 (1998) 391-394
23. Pasternack R., Vuorinen P., and Miettinen A. Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol 35 (1997) 676-678
24. Semeniuk H., Zentner A., Read R., and Church D. Evaluation of sequential testing strategies using non-amplified and amplified methods for detection of Chlamydia trachomatis in endocervical and urine specimens from women. Diagn Microbiol Infect Dis 42 (2002) 43-51
25. Gallo D., George J.R., Fitchen J.H., Goldstein A.S., and Hindahl M.S. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group. JAMA 277 (1997) 254-258
26. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 51 RR 6 (2002) 1-78
27. Blake D.R., Gaydos C.A., and Quinn T.C. Cost-effectiveness analysis of screening adolescent males for chlamydia on admission to detention. Sex Transm Dis 31 (2004) 85-95
28. Genc M., and Mardh P.A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 124 (1996) 1-7
29. Marrazzo J.M., Celum C.L., Hillis S.D., Fine D., DeLisle S., and Handsfield H.H. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Sex Transm Dis 24 (1997) 131-141
30. Lubelchek R., Kroc K., Hota B., et al. The role of rapid vs. conventional human immunodeficiency virus testing for inpatients: effects on quality of care. Arch Intern Med 165 (2005) 1956-1960
31. Chou R., Smits A.K., Huffman L.H., Fu R., Korthuis P.T., and U.S. Preventive Services Task Force. Prenatal screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 143 (2005) 38-54
32. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. MMWR Morb Mortal Wkly Rep 55 R14 (2006) 1-17